The Role of Folliculin in Amino Acid Sensing SPECIFIC AIMS Birt-Hogg Dubé (BHD) syndrome is a rare autosomal dominant condition that’s characterized by the development of benign skin tumors and lung cysts. Moreover, these manifestations increase patients’ risk to develop renal cell carcinoma (RCC) and/or pneumothorax. Germline mutations in the Folliculin (FLCN) gene are responsible for patients to express the clinical hallmarks of BHD. Most of the BHD patient population contain mutations in the FLCN
The Role of Folliculin in Amino Acid Sensing Specific Aims Birt-Hogg Dubé (BHD) syndrome is a rare autosomal dominant condition that’s characterized by the development of benign skin tumors and lung cysts. Moreover, these manifestations increase patients’ risk to develop renal cell carcinoma (RCC) and/or pneumothorax. Germline mutations in the Folliculin (FLCN) gene are responsible for the onset of BHD, resulting in its loss-of-function. Furthermore, BHD clinical hallmarks are similar to the clinical
Birt-Hogg-Dubé (BHD) syndrome is a rare inherited autosomal dominant disorder caused by germline mutations in the folliculin (FLCN) gene (Nookala et al., 2012; Nickerson et al., 2002; Menko et al., 2012; Hartman et a., 2009). BHD patients develop fibrofolliculomas and lung cysts increasing their risk to develop renal cell carcinoma (RCC) and pneumothorax (Nookala et a., 2012; Menko et al., 2012; Hartman et al., 2009). The majority of the BHD patient population contain germline mutations in FLCN exon
1.1 Birt-Hogg-Dubé Syndrome Birt-Hogg-Dubé (BHD) syndrome (OMIM 135150) is a rare, autosomal dominant, hamartoma disorder which is characterized by benign tumours of the hair follicle (fibrofolliculomas), lung cysts and pneumothorax (collapsed lung), and renal neoplasia. BHD was first described in 1977 by three Canadian doctors – Birt, Hogg and Dubé (Birt et al. 1977). The syndrome had also been identified 1975 by Hornstein and Knickenberg (Hornstein & Knickenberg 1975) and there has been suggestion
Birt-Hogg-Dubé (BHD) syndrome is a rare inherited autosomal dominant disorder caused by germline mutations in the folliculin (FLCN) gene [1–4]. Patients with BHD initially develop fibrofolliculomas, typically as benign facial tumors, and lung cysts; whereby, increasing their risk to develop renal cell carcinoma (RCC) and pneumothorax [1,3,4]. The majority of the BHD patient population contain germline mutations in FLCN exon 11, a hotspot for disease causing mutations. BHD research predicts FLCN mutations